Risk of Adverse Drug Events Observed with Baricitinib 2 mg Versus Baricitinib 4 mg Once Daily for the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2014 ◽
Vol 6
(6)
◽
pp. 621-630
◽
2013 ◽
Vol 71
(Suppl 3)
◽
pp. 207.3-208
◽
2010 ◽
Vol 31
(11)
◽
pp. 1493-1499
◽
2010 ◽
Vol 39
(4)
◽
pp. 271-278
◽
2019 ◽